In AD patients, there was no statistical difference in FDX1 mRNA relative expression levels between APOE ε4+ and APOE ε4− individuals, but there was differential expression between APOE ε4/ε4 and APOE ε2, ε3/ε4 individuals (p < 0.05) (Figure 9). Here, APOE is linked to Alzheimer disease.